News, Articles and Updates

Behavioral Health

Behavioral Health News Journal of Clinical Psychiatry 4:00 am Prescription Patterns in Canadian Operational Stress Injury Clinics: An In-Depth Examination of Posttraumatic Stress Disorder Treatment Practices Original Source: Journal of Clinical Psychiatry, all rights reserved. — posttraumatic stress disorder (PTSD) is highly prevalent among military and public safety personnel and is frequently accompanied by comorbid conditions such as depression, anxiety, chronic pain, and substance use disorders.1 Across countries, clinical practice guidelines… Behavioral Health Industry News 3:13 pm AHA podcast discusses teen use of AI chatbots and mental health risks  Christine Moutier, M.D., chief medical officer at the American Foundation for Suicide Prevention, discusses the usage of artificial intelligence chatbots among adolescents, the potential dangers for young people experiencing mental health challenges, and the importance of educating clinicians and families about this new technology. LISTEN… Behavioral Health Industry News 12:07 pm HHS Analysis Does Not Establish a Causal Link Between Medicaid Provider Taxes and Commercial Premiums A recent issue brief from the Department of Health and Human Services asserts that Medicaid hospital provider taxes raise employer-sponsored insurance premiums. It projects that lowering the limit on those taxes could reduce premiums by as much as 2.5% by 2032. However, the analysis is… Behavioral Health News Journal of Clinical Psychiatry 4:00 am Nephophobia: A Case of Specific Phobia of White Clouds Coexisting With Acrophobia Original Source: Journal of Clinical Psychiatry, all rights reserved. — Specific phobia is among the most prevalent anxiety disorders in epidemiological surveys.1 The DSM-5 classifies specific phobias into 5 subtypes: animal, natural environment, blood-injection-injury, situational, and other. Within the natural environment subtype, acrophobia (fear of… Behavioral Health News Journal of Clinical Psychiatry 4:00 am Efficacy of Lumateperone 42 mg in Major Depressive Disorder: Subgroup Analysis of a Phase 3 Randomized, Placebo-Controlled Trial Original Source: Journal of Clinical Psychiatry, all rights reserved. — Major depressive disorder (MDD) is a highly burdensome disorder characterized by heterogeneous symptoms and variable disease progression, with variations in age of onset, duration of depressive episodes, and number of lifetime episodes.1 The lifetime prevalence… Behavioral Health News Journal of Clinical Psychiatry 12:05 am Treating Alzheimer’s Agitation, Not Just Quieting It with Pierre N. Tariot, MD Original Source: Journal of Clinical Psychiatry, all rights reserved. — Listen on your favorite platform Episode Overview In this episode of The JCP Podcast, host Dr. Ben Everett speaks with Dr. Pierre N. Tariot, director of the Banner Alzheimer’s Institute and research professor of psychiatry… Behavioral Health News Journal of Clinical Psychiatry 4:00 am Establishing the Clinical Role of Digital Therapeutics in Major Depressive Disorder Treatment: A Consensus Panel Perspective Original Source: Journal of Clinical Psychiatry, all rights reserved. — This Academic Highlights section of The Journal of Clinical Psychiatry presents the highlights of the virtual consensus panel meeting “Defining the Clinical Role of Digital Therapeutics in Major Depressive Disorder,” which was held May 6,… Behavioral Health News Journal of Clinical Psychiatry 4:00 am Ketamine/Esketamine in Clinical Practice: Areas of Consensus and Nonconsensus from an American Society of Clinical Psychopharmacology (ASCP) Delphi Panel Task Force Original Source: Journal of Clinical Psychiatry, all rights reserved. — The discovery of ketamine’s antidepressant actions has dramatically impacted how psychiatry is practiced and helped change the landscape for antidepressant drug development. Since publication of the seminal paper showing ketamine’s rapid-onset antidepressant effects,1 there have… Behavioral Health News Journal of Clinical Psychiatry 4:00 am Sibling Psychiatric Diagnoses and Risk of Postpartum Psychosis: A Nationwide Cohort Study Original Source: Journal of Clinical Psychiatry, all rights reserved. — Postpartum psychosis is one of the most acute psychiatric emergencies associated with childbirth, affecting approximately 1–2 per 1,000 women.1–3 Onset typically occurs within weeks after delivery and is marked by rapid-onset mania, depression with psychotic… Behavioral Health News Journal of Clinical Psychiatry 4:00 am A Case of Oral Budesonide–Induced Psychosis Original Source: Journal of Clinical Psychiatry, all rights reserved. — Psychiatric side effects from systemic corticosteroids are relatively common, with severe reactions affecting approximately 6% of patients on agents such as prednisone and dexamethasone.1 Most cases involve mood disorders, with around one-sixth featuring psychosis or… Behavioral Health News Journal of Clinical Psychiatry 4:00 am Depression in the Context of Medical Illness: Evaluation, Management, and the Risk of Suicide Original Source: Journal of Clinical Psychiatry, all rights reserved. — Have you ever wondered whether depression that develops in the context of a medical illness is understandable and not pathological? Have you been unsure about whether (and when) you should initiate treatment (eg, pharmacologic or… Behavioral Health Industry News 3:43 pm AHA releases new infographic on behavioral health The AHA has released its latest downloadable Fast Facts infographic providing statistics on the number of behavioral health hospitals and hospital services in the U.S. It also includes trend data on hospitals providing psychiatric screenings and on hospitals that are consulting/liaising behavioral healthcare with acute…

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.